[HTML][HTML] Exosomes released by human umbilical cord mesenchymal stem cells protect against cisplatin-induced renal oxidative stress and apoptosis in vivo and in …

Y Zhou, H Xu, W Xu, B Wang, H Wu, Y Tao… - Stem cell research & …, 2013 - Springer
Introduction Administration of bone marrow mesenchymal stem cells (MSCs) or secreted
microvesicles improves recovery from acute kidney injury (AKI). However, the potential roles …

[PDF][PDF] Exosomes released by human umbilical cord mesenchymal stem cells protect against cisplatin-induced renal oxidative stress and apoptosis in vivo and in vitro

Y Zhou, H Xu, W Xu, B Wang, H Wu, Y Tao, B Zhang… - 2013 - cyberleninka.org
Introduction: Administration of bone marrow mesenchymal stem cells (MSCs) or secreted
microvesicles improves recovery from acute kidney injury (AKI). However, the potential roles …

Exosomes released by human umbilical cord mesenchymal stem cells protect against cisplatin-induced renal oxidative stress and apoptosis in vivo and in vitro.

Y Zhou, H Xu, W Xu, B Wang, H Wu, Y Tao… - Stem Cell Research & …, 2013 - europepmc.org
Methods We constructed cisplatin-induced AKI rat models. At 24 h after treatment with
cisplatin, hucMSC-ex were injected into the kidneys via the renal capsule; human lung …

[HTML][HTML] Exosomes released by human umbilical cord mesenchymal stem cells protect against cisplatin-induced renal oxidative stress and apoptosis in vivo and in …

Y Zhou, H Xu, W Xu, B Wang… - … Cell Research & …, 2013 - stemcellres.biomedcentral.com
Administration of bone marrow mesenchymal stem cells (MSCs) or secreted microvesicles
improves recovery from acute kidney injury (AKI). However, the potential roles and …

[PDF][PDF] Exosomes released by human umbilical cord mesenchymal stem cells protect against cisplatin-induced renal oxidative stress and apoptosis in vivo and in vitro

Y Zhou, H Xu, W Xu, B Wang, H Wu, Y Tao, B Zhang… - 2013 - Citeseer
Introduction: Administration of bone marrow mesenchymal stem cells (MSCs) or secreted
microvesicles improves recovery from acute kidney injury (AKI). However, the potential roles …

[PDF][PDF] Exosomes released by human umbilical cord mesenchymal stem cells protect against cisplatin-induced renal oxidative stress and apoptosis in vivo and in vitro

Y Zhou, H Xu, W Xu, B Wang, H Wu, Y Tao, B Zhang… - 2013 - researchgate.net
Introduction: Administration of bone marrow mesenchymal stem cells (MSCs) or secreted
microvesicles improves recovery from acute kidney injury (AKI). However, the potential roles …

Exosomes released by human umbilical cord mesenchymal stem cells protect against cisplatin-induced renal oxidative stress and apoptosis in vivo and in vitro

Y Zhou, H Xu, W Xu, B Wang, H Wu… - Stem cell research …, 2013 - pubmed.ncbi.nlm.nih.gov
Introduction Administration of bone marrow mesenchymal stem cells (MSCs) or secreted
microvesicles improves recovery from acute kidney injury (AKI). However, the potential roles …

[引用][C] Exosomes released by human umbilical cord mesenchymal stem cells protect against cisplatin-induced renal oxidative stress and apoptosis in vivo and in vitro

Y Zhou, H Xu, W Xu, B Wang, H Wu, Y Tao… - Stem Cell Research & …, 2013 - cir.nii.ac.jp
Exosomes released by human umbilical cord mesenchymal stem cells protect against
cisplatin-induced renal oxidative stress and apoptosis in vivo and in vitro | CiNii Research …

[HTML][HTML] Exosomes released by human umbilical cord mesenchymal stem cells protect against cisplatin-induced renal oxidative stress and apoptosis in vivo and in …

Y Zhou, H Xu, W Xu, B Wang, H Wu, Y Tao… - Stem Cell Research & …, 2013 - ncbi.nlm.nih.gov
Methods We constructed cisplatin-induced AKI rat models. At 24 h after treatment with
cisplatin, hucMSC-ex were injected into the kidneys via the renal capsule; human lung …

[PDF][PDF] Exosomes released by human umbilical cord mesenchymal stem cells protect against cisplatin-induced renal oxidative stress and apoptosis in vivo and in vitro

Y Zhou, H Xu, W Xu, B Wang, H Wu, Y Tao, B Zhang… - 2013 - core.ac.uk
Introduction: Administration of bone marrow mesenchymal stem cells (MSCs) or secreted
microvesicles improves recovery from acute kidney injury (AKI). However, the potential roles …